Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 14, 2019, after the close
10-Q filed May 14, 2019, 44 days after period end · 0001171843-19-003354
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | $2.50K | $2.50K |
| Net Income | -$3.11M | -$2.15M | -$7.57M | -$6.61M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$3.42 |
| -$0.14 |
| -$0.68 |
| -$0.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
